Cardlytics Proceeds Revenue Tightening Amidst Failing Business Economics (NASDAQ: CDLX)

.Financial author advises selling Cardlytics, Inc. because of declining system economics, income obstacles, and also adverse economic trends. Click for this CDLX improve.